RE: RNS Trading Statement8 Feb 2021 07:38
In Europe, the Group achieved CE mark approval for OrthoPure® XT, a decellularised porcine tendon for use in the repair or reconstruction of knee ligaments, and the first products were shipped in December 2020.
Distribution partners have been secured in the UK and Poland and the Group is actively engaged in a number of discussions with partners in other key European territories which are expected to materialise during 2021.
Sounds very promising.